Companies: 10,795·Total market cap: $144.5T
Enzolytics Inc.

Enzolytics Inc.

ENZCOTCHealthcare● Active
$0.00
+$0.00(+10.00%)
Market Cap$4335804
P/E Ratio—
52W High$0.0012
52W Low$0.0002
SEC Filings

Enzolytics Inc. (ENZC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001421851 · ENZC · OTC · as of Jun 9, 2026

Filing snapshot

61
Total Filings
8-K
Latest Form
2020-04-16
Most Recent
2009
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001421851 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2011-11-01
Fiscal Year End
Nov 1, 2011
Accession No.
0001477932-11-002275
Primary Document
setc_10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001421851 · Accession 0001477932-11-002275

Latest Key Filings

10-QQuarterly Report
JUNE 30, 2011 QUARTERLY REPORT
2017-09-15
View 10-Q on SEC
8-KCurrent Report
FORM 8-K CURRENT REPORT
2020-04-16Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K CURRENT REPORT
2020-04-16
View
8-KCurrent Report
FORM 8K CURRENT REPORT
2019-08-13
View
10-QQuarterly Report
JUNE 30, 2011 QUARTERLY REPORT
2017-09-15
View
15-15D15-15D
FORM 15-15D
2011-11-08
View
10-Q/AQuarterly Report (Amended)
FORM 10-Q/A
2011-11-01
View
10-K/AAnnual Report (Amended)
FORM 10-K/A
2011-11-01
View
10-QQuarterly Report
FORM 10-Q
2011-05-23
View
10-KAnnual Report
FORM 10-K
2011-05-19
View
8-KCurrent Report
FORM 8-K
2011-05-17
View
8-KCurrent Report
FORM 8-K
2011-05-17
View
NT 10-Q/ANT 10-Q/A
FORM NT-10Q/A
2011-05-16
View
NT 10-QNT 10-Q
FORM NT-10Q
2011-05-13
View
8-KCurrent Report
Current Report
2011-04-05
View
NT 10-KNT 10-K
NT 10-K
2011-03-30
View
8-KCurrent Report
Current Report
2010-11-23
View
Showing 1–15 of 59 filingsForm 4 / 144 hidden· 61 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001421851  |  Exchange: OTC · Healthcare

Enzolytics Inc. (OTC: ENZC) has submitted 61 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001421851, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Enzolytics Inc.'s most comprehensive regulatory disclosure. The most recent Enzolytics Inc. 10-K was filed on 2011-11-01 for fiscal year ending 2011. Historical ENZC 10-K annual reports are available from 2008 through 2011.

Investors researching Enzolytics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MDGEF SEC Filings →BMNDF SEC Filings →VCNX SEC Filings →STMM SEC Filings →NBCO SEC Filings →ISCO SEC Filings →CNNA SEC Filings →BICTF SEC Filings →
→ ENZC Financials→ ENZC Earnings→ ENZC Insider Trades

Frequently Asked Questions

ENZC SEC Filings · 8 questions

Enzolytics Inc. (ENZC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 61 filings and access original documents at no cost. Enzolytics Inc.'s CIK is 0001421851.

ENZC SEC filingsEnzolytics Inc. SEC documentsfind ENZC 10-K